Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Concordance Between Circulating Tumor DNA Assay and Foundation One Tissue Analysis For Genomic Alterations

NCT02620527 is registered in ClinicalTrials.gov with Foundation Medicine as lead sponsor.

NCT NCT02620527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Concordance Between Circulating Tumor DNA Assay and Foundation One Tissue Analysis For Genomic Alterations
Lead sponsor
Foundation Medicine
Phase
Observational
Overall status
Completed
Start date
November 30, 2014
Completion date
December 31, 2017
Enrollment
1,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, circulating tumor dna, genomic alterations, genomic testing, neoplasms